| the Weizmann Institute, Ph.D |
AIT Co-Founder and CSO, Professor Reiter is a world leader in the isolation of human TCRL molecules. Head of the Laboratory of Molecular Immunology at the Technion Institute, Prof. Reiter established a cutting-edge research program in the molecular immunology of cancer. His major work involves the development of novel immunotherapeutic approaches, as well as the study of molecular mechanisms in anti-tumor and anti-viral immunity. Prof. Reiter received his PhD from the Department of Immunology at the Weizmann Institute and subsequently spent 5 years at the NCI Laboratory of Molecular Biology headed by Dr. Ira Pastan, where he developed new approaches in antibody engineering. Prof. Reiter has published over 100 scientific papers and reviews, and holds 15 patents. He currently serves as an advisor to several pharmaceutical and biotechnology companies.
